Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

NCT02443194 is registered in ClinicalTrials.gov with michal roll as lead sponsor.

NCT NCT02443194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02443194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
Lead sponsor
michal roll
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2015
Completion date
November 30, 2015
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

depression